Awarded: Sep 15, 2016
$300,000 over 3 years
To provide continued support for research on effective and safe use of hydroxyurea in Ugandan children with sickle cell disease who live in a region with widespread malaria.
Awarded: Sep 15, 2016
$300,000 over 3 years
To provide continued support for research on effective and safe use of hydroxyurea in Ugandan children with sickle cell disease who live in a region with widespread malaria.